Assisted reproductive technology for men and women infected with human immunodeficiency virus type 1.
In 2001, the World Health Organization reported 4.3 million new human immunodeficiency virus (HIV) infections in adults globally, 41% of which were in women. During the year 2000, 27% of newly diagnosed HIV infections in the United States occurred in women. In developed countries, the perception of HIV infection has changed from an acute, lethal infection to a chronic illness; the introduction of highly active antiretroviral therapy has decreased morbidity and mortality, and new drug therapies have dramatically decreased perinatal transmission. In view of these advances, some HIV-infected individuals are considering reproduction. Following the lead of organizations in other developed countries, the American College of Obstetricians and Gynecologists has recently endorsed the use of reproductive technology in HIV-infected patients. Which patients should be offered assisted reproduction and what the optimal methods are of decreasing heterosexual and perinatal HIV transmission must be determined.
Al-Khan
Anthony
A
Department of Obstetrics, Gynecology, and Women's Health, New Jersey Medical School, Newark, NJ 07103, USA.
Colon
Jose
J
Palta
Vidya
V
Bardeguez
Arlene
A
D005260:Female; D015658:HIV Infections / Q000503:physiopathology*; D018023:HIV Seronegativity; D006679:HIV Seropositivity; D015497:HIV-1; D006801:Humans; D007753:Laboratories; D008297:Male; D009774:Obstetrics; D027724:Reproductive Techniques, Assisted